Dynamic Contrast-Enhanced Magnetic Resonance Imaging as a Surrogate Biomarker for Bevacizumab in Colorectal Cancer Liver Metastasis: A Single-Arm, Exploratory Trial

PURPOSE: The purpose of this study is to investigate dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and plasma cytokines and angiogenic factors (CAFs) as pharmacodynamic and prognostic biomarkers of bevacizumab monotherapy in colorectal cancer with liver metastasis (CRCLM). MATERIALS...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cancer Res Treat
Autori principali: Kim, Yeo-Eun, Joo, Bio, Park, Mi-Suk, Shin, Sang Joon, Ahn, Joong Bae, Kim, Myeong-Jin
Natura: Artigo
Lingua:Inglês
Pubblicazione: Korean Cancer Association 2016
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5080817/
https://ncbi.nlm.nih.gov/pubmed/26987390
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2015.374
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi